Order Rybelsus

 

In September 2025, Novo Nordisk — the manufacturer of Rybelsus — introduced a completely reformulated version of the medication across all dose strengths. The entire range has changed: 3mg has become 1.5mg, 7mg has become 4mg, and 14mg has become 9mg.

 

The 14mg tablet has been officially discontinued and is no longer available to prescribe or dispense anywhere in the UK.

​

The reason for this change is a significant improvement in how the new tablets are absorbed by the body. The reformulated Rybelsus is more bioavailable, meaning your body absorbs the active ingredient — semaglutide — more efficiently than before.

 

This is why a lower dose number delivers exactly the same clinical effect. Your treatment has not been reduced; the medicine has simply been made more effective at a lower dose.

​

You may also notice that both the tablets themselves and the packaging are slightly smaller than before — this is entirely expected with the new formulation.

​

If you have any questions or concerns about your prescription, please do not hesitate to speak with one of our clinicians. We are happy to talk you through what this change means for you personally.

​

Whatsapp: +447803440539